PharmBioTec gGmbH
PharmBioTec gGmbH is a non-profit German contract research organization specializing in preclinical pharmaceutical research using animal-free in vitro and ex vivo methods, HPLC-MS/MS proteomics, and human cell-based disease models, serving pharmaceutical companies and academic institutions.
- Company typePrivate
- Founded2010
- HeadquartersSchiffweiler, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
PharmBioTec gGmbH firmographics
Firmographics- Name
- PharmBioTec gGmbH
- Legal name
- PharmBioTec gGmbH
- Website
- https://pharmbiotec.de
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PharmBioTec gGmbH is a non-profit German contract research organization specializing in preclinical pharmaceutical research using animal-free in vitro and ex vivo methods, HPLC-MS/MS proteomics, and human cell-based disease models, serving pharmaceutical companies and academic institutions.
- Ownership category
- akta.pro rank
PharmBioTec gGmbH industry classification
Industry- Product category
- Pharmaceutical Contract Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industry
- Formulation & Preclinical CMC Support (Nonclinical) (HLAGAFAL)
Keywords
Where PharmBioTec gGmbH is headquartered
LocationHeadquarters
- HQ city
- Schiffweiler
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
PharmBioTec gGmbH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Contract Research Services: Fee-for-service pharmaceutical contract research including formulation development, analytical services, and in vitro testing conducted on behalf of industrial partners and research institutions.
- Joint Research Projects: Collaborative research projects with partners from industry and academia, often funded by government programs (EFRE, INNO-KOM, ZIM) and aimed at developing new methods or product innovations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
PharmBioTec gGmbH product offering
Product offeringCore offering
PharmBioTec gGmbH is a non-profit contract research organization providing preclinical pharmaceutical research services, including formulation development, in vitro efficacy and safety testing using cell and tissue models, and analytical services such as HPLC and HPLC-MS. The offering targets industrial clients in pharmaceuticals, cosmetics, and chemicals as well as academic research partners, with a particular emphasis on animal-free methods (NAMs).
Product overview
PharmBioTec gGmbH is a non-profit contract research organization offering a portfolio of pharmaceutical research and development services. The core offerings include: (1) Non-Profit Research services focused on developing alternatives to animal testing using NAMs (New Approach Methodologies), with current projects including SaAr in vitro, MucPower, and IMPACT; (2) Formulation Development services creating innovative formulations such as inhalation systems, nasal sprays, creams, and nanocarriers; (3) In vitro Efficacy & Safety Testing using established cell and tissue models; (4) Bioequivalence Studies including permeation testing; and (5) Analytics services including HPLC-MS analyses. The company operates from the Pharmacampus in Schiffweiler, Germany, and collaborates with industry partners and academic institutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Formulation Development Preclinical formulation development services for pharmaceutical and cosmetics clients, supporting early-stage development of dosage forms and test articles that subsequently feed into in vitro testing programs.
- In Vitro Efficacy and Safety Testing Animal-free in vitro testing services using cell-based models, reconstructed human skin and mucosa models, and other New Approach Methodologies (NAMs) to assess efficacy and safety of pharmaceutical, cosmetic, and chemical compounds.
- Analytical Services (HPLC and HPLC-MS) Analytical chemistry services using HPLC and HPLC-MS, including mass spectrometry-based proteomics workflows, for compound characterization, stability studies, and bioanalytical support of preclinical research.
- Publicly Funded Collaborative Research Projects Collaborative, grant-funded research projects with universities, research institutes, and industry partners to advance animal-free testing methods, in vitro models, and analytical technologies.
Quantifiable outcome
- Successfully published first results from EFRE-funded SaAr in vitro project in European Journal of Pharmaceutics and Biopharmaceutics (2025)
Companies that use PharmBioTec gGmbH
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
PharmBioTec gGmbH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
PharmBioTec gGmbH partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered minor and core.
- 3R-Plattform SaarminorPlatform for making alternative methods (3R: Replacement, Reduction, Refinement) available to other researchers.
- Jagiellonian University PolandcoreCollaborative research on neurodegenerative diseases (Alzheimer's and Parkinson's) developing selenium-containing 5-HT6R ligands as innovative treatments.
- PSM GmbHcoreCo-located at Pharmacampus in Schiffweiler. PSM is a Contract Development and Manufacturing Organization (CDMO) providing GMP manufacturing. Companies share technical interfaces and collaborate on projects.
- FU Berlin (Prof. Daniel Lauster)coreEFRE cooperation project MucPower for lectin-based formulations against herpes and Pseudomonas infections, along with MucosaTec GmbH.
- MucosaTec GmbHcoreCollaboration in SPRIN-D Challenge project MucBoost for broad-spectrum antivirals. PharmBioTec responsible for formulation development using animal-free methods. MucosaTec has labs in Berlin (development/manufacturing) and Schiffweiler (analytics & formulation development).
- Sapienza University RomecoreEU-funded collaborative research project on green chemistry and drug development. Project focuses on integrating environmentally friendly chemical processes into innovative drug development with minimal environmental impact.
- Universität des SaarlandescoreAcademic partner in multinational research collaboration on neurodegenerative diseases and other drug development projects. PharmBioTec originated as spin-off from this university.
- MannKind Corp.minorMet at ISAM Congress 2023, one of several industry connections established during conference participation.
- VITROCELL SystemsminorMet at ISAM Congress 2023, one of several industry connections established during conference participation.
- Free University of BerlincoreAcademic collaboration with Prof. Daniel Lauster's team on SPRIN-D MucBoost project and other initiatives.
- Helmholtz Institute for Pharmaceutical Research SaarlandminorMet at ISAM Congress 2023, one of several industry and research connections established during conference participation.
Scale indicators3 records
Recent moves9 records
Expansion highlights6 records
PharmBioTec gGmbH competitors and assessment
Company assessmentDirect peers
- InSphero AG: Swiss 3D cell model company providing in vitro liver, pancreatic and other microtissue assays for preclinical drug testing. Comparable as a NAM-focused preclinical CRO serving pharma with proprietary cell-based disease models.
- Emulate, Inc. US organ-on-chip CRO commercializing the Emulate platform for in vitro disease modeling and drug testing. Comparable as a NAM-focused preclinical CRO with proprietary cell-based disease models used by pharma.
- Kirkstall Ltd: UK-based company developing organ-on-chip and in vitro cell culture systems for preclinical drug testing, with a strong 3R alternative-testing orientation. Highly comparable as a NAM-focused preclinical testing provider serving pharma customers.
- CN Bio Innovations: UK organ-on-chip company offering single- and multi-organ microphysiological systems for preclinical drug development, including lung and intestinal models. Direct peer in the NAM/organ-on-chip preclinical testing space.
- Mimetas B.V. Dutch organ-on-chip company commercializing the OrganoPlate platform for preclinical drug development and disease modeling. Comparable as a NAM-focused European CRO with proprietary in vitro disease modeling technology.
- TissUse GmbH: Berlin-based multi-organ-chip company developing microphysiological systems for preclinical drug testing and 3R-aligned research. Comparable as a German/European NAM CRO with overlapping lung and intestinal modeling focus.
- Evotec SE: Hamburg-based global contract research organization offering preclinical drug discovery services including in vitro and alternative testing models. Closely comparable business model and customer base (pharma industry) to PharmBioTec, with overlapping focus on early-stage R&D services.
- Bioneer A/S: Danish preclinical CRO providing in vitro pharmacology, cell-based assays and molecular biology services to pharma. Comparable as a smaller specialized European CRO with NAM-aligned in vitro service offerings.
- Inotiv, Inc. US preclinical CRO providing drug discovery, safety assessment and research models, with explicit investments in NAMs and 3R-aligned in vitro assays. Directly comparable as a preclinical CRO serving pharma with alternative testing capabilities.
Broad incumbents
- Charles River Laboratories: Large global CRO offering preclinical research services including safety assessment, discovery and research models. Operates broadly across the same preclinical CRO category as PharmBioTec but at vastly greater scale and with a wider portfolio beyond NAMs.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
PharmBioTec gGmbH social profiles
Digital presencePharmBioTec gGmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmBioTec gGmbH leadership team
Management profileNumber of profiles
Profiles6 records
PharmBioTec gGmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmBioTec gGmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmBioTec gGmbH
What does PharmBioTec gGmbH do?
PharmBioTec gGmbH is a non-profit contract research organization providing preclinical pharmaceutical research services, including formulation development, in vitro efficacy and safety testing using cell and tissue models, and analytical services such as HPLC and HPLC-MS. The offering targets industrial clients in pharmaceuticals, cosmetics, and chemicals as well as academic research partners, with a particular emphasis on animal-free methods (NAMs).
Is PharmBioTec gGmbH a public or private company?
PharmBioTec gGmbH is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was PharmBioTec gGmbH founded?
PharmBioTec gGmbH was founded in 2010. It employs 1 to 10 people.
Where is PharmBioTec gGmbH based?
PharmBioTec gGmbH is headquartered in Schiffweiler, Germany, in the Europe region.
How does PharmBioTec gGmbH make money?
Two revenue lines are on record. Contract Research Services are the primary driver. The others are joint Research Projects.
Who are PharmBioTec gGmbH's main competitors?
Direct peers on record are InSphero AG, Emulate, Inc., Kirkstall Ltd, CN Bio Innovations, Mimetas B.V., TissUse GmbH, Evotec SE, Bioneer A/S and Inotiv, Inc.. Charles River Laboratories is listed as a broad incumbent.
Does PharmBioTec gGmbH have an API?
No public API is recorded for PharmBioTec gGmbH.
What industry is PharmBioTec gGmbH in?
PharmBioTec gGmbH's product category is Pharmaceutical Contract Research Services. Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAGAFAL, Formulation & Preclinical CMC Support (Nonclinical). Its NAICS code is 5417 and its SIC code is 8731.